{"id":"https://openalex.org/W2138784254","doi":"https://doi.org/10.1093/rheumatology/ken363","title":"IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF- and IL-17","display_name":"IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF- and IL-17","publication_year":2008,"publication_date":"2008-08-13","ids":{"openalex":"https://openalex.org/W2138784254","doi":"https://doi.org/10.1093/rheumatology/ken363","mag":"2138784254","pmid":"https://pubmed.ncbi.nlm.nih.gov/18786965"},"language":"en","primary_location":{"id":"doi:10.1093/rheumatology/ken363","doi":"https://doi.org/10.1093/rheumatology/ken363","is_oa":false,"landing_page_url":"https://doi.org/10.1093/rheumatology/ken363","pdf_url":null,"source":{"id":"https://openalex.org/S183989336","display_name":"Rheumatology","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2138784254"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112132939","display_name":"Misato Hashizume","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M. Hashizume","raw_affiliation_strings":["Product Research Department, Chugai Pharmaceutical Co. Ltd, Komakado, Gotemba, Shizuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Research Department, Chugai Pharmaceutical Co. Ltd, Komakado, Gotemba, Shizuoka, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111951255","display_name":"Naohiko Hayakawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"N. Hayakawa","raw_affiliation_strings":["Product Research Department, Chugai Pharmaceutical Co. Ltd, Gotemba, Shizuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Research Department, Chugai Pharmaceutical Co. Ltd, Gotemba, Shizuoka, Japan","institution_ids":["https://openalex.org/I4405254473"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5066076081","display_name":"Masahiko Mihara","orcid":"https://orcid.org/0000-0002-0792-4009","observed_orcids":["https://orcid.org/0000-0002-0792-4009"]},"institutions":[{"id":"https://openalex.org/I4405254473","display_name":"Chugai Pharmaceutical Co., Ltd. (Japan)","ror":"https://ror.org/01v743b94","country_code":"JP","type":"company","lineage":["https://openalex.org/I4405254473"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M. Mihara","raw_affiliation_strings":["Product Research Department, Chugai Pharmaceutical Co. Ltd, Gotemba, Shizuoka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Product Research Department, Chugai Pharmaceutical Co. Ltd, Gotemba, Shizuoka, Japan","institution_ids":["https://openalex.org/I4405254473"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4405254473"],"apc_list":{"value":3486,"currency":"GBP","value_usd":4597},"apc_paid":null,"fwci":8.5834,"has_fulltext":false,"cited_by_count":355,"citation_normalized_percentile":{"value":0.98041575,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"47","issue":"11","first_page":"1635","last_page":"1640"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.88919997215271,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.88919997215271,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.10580000281333923,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13026","display_name":"Natural Compounds in Disease Treatment","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2707","display_name":"Complementary and alternative medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-6-trans-signalling","display_name":"IL-6 trans-signalling","score":0.9279999732971191},{"id":"https://openalex.org/keywords/soluble-il-6-receptor","display_name":"soluble IL-6 receptor","score":0.9259999990463257},{"id":"https://openalex.org/keywords/synovial-fibroblasts","display_name":"synovial fibroblasts","score":0.9800000190734863},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9520000219345093},{"id":"https://openalex.org/keywords/il-17","display_name":"IL-17","score":1.0},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.9340000152587891},{"id":"https://openalex.org/keywords/stat3-phosphorylation","display_name":"STAT3 phosphorylation","score":0.718999981880188},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.9509999752044678},{"id":"https://openalex.org/keywords/jak-stat-signaling","display_name":"JAK/STAT signaling","score":0.781000018119812},{"id":"https://openalex.org/keywords/nfatc1","display_name":"NFATc1","score":0.9700000286102295},{"id":"https://openalex.org/keywords/parthenolide","display_name":"parthenolide","score":0.9520000219345093},{"id":"https://openalex.org/keywords/pd98059","display_name":"PD98059","score":0.9300000071525574},{"id":"https://openalex.org/keywords/synovial-hyperplasia","display_name":"synovial hyperplasia","score":0.7279999852180481}],"concepts":[{"id":"https://openalex.org/C2779428903","wikidata":"https://www.wikidata.org/wiki/Q418934","display_name":"RANKL","level":4,"score":0.8300204873085022},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5071816444396973},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.4885152578353882},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4718703627586365},{"id":"https://openalex.org/C88045685","wikidata":"https://www.wikidata.org/wiki/Q174576","display_name":"Activator (genetics)","level":3,"score":0.4459124207496643},{"id":"https://openalex.org/C171958077","wikidata":"https://www.wikidata.org/wiki/Q419333","display_name":"STAT protein","level":4,"score":0.44189855456352234},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4309699237346649},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.4212586283683777},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3618570566177368},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35517555475234985},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33515530824661255},{"id":"https://openalex.org/C2778923194","wikidata":"https://www.wikidata.org/wiki/Q14912019","display_name":"STAT3","level":3,"score":0.327009379863739},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2764741778373718},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.26618868112564087}],"mesh":[{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005347","descriptor_name":"Fibroblasts","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005419","descriptor_name":"Flavonoids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D012717","descriptor_name":"Sesquiterpenes","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013268","descriptor_name":"Stimulation, Chemical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013583","descriptor_name":"Synovial Membrane","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013583","descriptor_name":"Synovial Membrane","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D014409","descriptor_name":"Tumor Necrosis Factor-alpha","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015153","descriptor_name":"Blotting, Western","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D015850","descriptor_name":"Interleukin-6","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019947","descriptor_name":"Receptors, Interleukin-6","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D019947","descriptor_name":"Receptors, Interleukin-6","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D020133","descriptor_name":"Reverse Transcriptase Polymerase Chain Reaction","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D020381","descriptor_name":"Interleukin-17","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D020929","descriptor_name":"Mitogen-Activated Protein Kinase Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D020929","descriptor_name":"Mitogen-Activated Protein Kinase Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D050796","descriptor_name":"STAT3 Transcription Factor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053245","descriptor_name":"RANK Ligand","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D053245","descriptor_name":"RANK Ligand","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D053245","descriptor_name":"RANK Ligand","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D053246","descriptor_name":"Receptor Activator of Nuclear Factor-kappa B","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D053583","descriptor_name":"Interleukin-1beta","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/rheumatology/ken363","doi":"https://doi.org/10.1093/rheumatology/ken363","is_oa":false,"landing_page_url":"https://doi.org/10.1093/rheumatology/ken363","pdf_url":null,"source":{"id":"https://openalex.org/S183989336","display_name":"Rheumatology","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},{"id":"pmid:18786965","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18786965","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology (Oxford, England)","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.549.8592","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.549.8592","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://rheumatology.oxfordjournals.org/content/47/11/1635.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.891.3043","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.891.3043","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://rheumatology.oxfordjournals.org/content/early/2008/09/11/rheumatology.ken363.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320324799","display_name":"Tokyo Medical and Dental University","ror":"https://ror.org/051k3eh31"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W174840698","https://openalex.org/W1534645474","https://openalex.org/W1587866859","https://openalex.org/W1964066819","https://openalex.org/W1979347549","https://openalex.org/W1981803131","https://openalex.org/W1995997868","https://openalex.org/W2003284223","https://openalex.org/W2003733256","https://openalex.org/W2004616124","https://openalex.org/W2017223857","https://openalex.org/W2017372504","https://openalex.org/W2022063700","https://openalex.org/W2027458529","https://openalex.org/W2035936653","https://openalex.org/W2036368043","https://openalex.org/W2044561904","https://openalex.org/W2047262791","https://openalex.org/W2048299560","https://openalex.org/W2097520274","https://openalex.org/W2098840577","https://openalex.org/W2109833522","https://openalex.org/W2110555227","https://openalex.org/W2139339400","https://openalex.org/W2141063536","https://openalex.org/W2153869151","https://openalex.org/W2162104177","https://openalex.org/W2165114168","https://openalex.org/W2165962369","https://openalex.org/W2299544063","https://openalex.org/W2461392396"],"related_works":["https://openalex.org/W2144892517","https://openalex.org/W3096874328","https://openalex.org/W2325912711","https://openalex.org/W2107782714","https://openalex.org/W2109833522","https://openalex.org/W2109134094","https://openalex.org/W2184900550","https://openalex.org/W6940037757","https://openalex.org/W2102069294","https://openalex.org/W3031290420"],"abstract_inverted_index":{"OBJECTIVES:":[0],"We":[1],"investigated":[2],"the":[3,8,72,111,117,148,172,183,251],"influence":[4,118],"of":[5,10,43,74,99,113,119,124,174,185,199],"cytokines":[6,61],"on":[7,122],"expression":[9,42,83,130,135,189,229],"RANK":[11],"ligand":[12],"(RANKL)":[13],"in":[14,71,84,110,171,192,203,230],"fibroblast-like":[15],"synoviocytes":[16],"from":[17],"RA":[18],"patients":[19],"(RA-FLS).":[20],"METHODS:":[21],"RA-FLS":[22,57,65,89,231],"were":[23,58,66],"stimulated":[24,164],"by":[25,47,138,145,209,239,246,250],"IL-6,":[26],"TNF-alpha,":[27,160],"IL-17":[28,153,161,178],"and":[29,52,79,97,115,126,128,144,152,167,201,205,211,232,241],"IL-1beta":[30,163],"with":[31,60,68,92],"or":[32,103,162,177],"without":[33],"soluble":[34],"IL-6":[35,142,168],"receptor":[36],"(sIL-6R)":[37],"for":[38,62,76,236],"24":[39],"h.":[40],"The":[41],"RANKL":[44,129,134,157,180,218,228,237,244],"was":[45,87,90,131,136,190,206],"measured":[46],"real-time":[48],"PCR,":[49],"western":[50],"blotting":[51],"immunostaining.":[53],"In":[54],"proliferation":[55],"assay,":[56],"cultured":[59,91],"3":[63,77],"days.":[64],"co-cultured":[67],"RAW":[69,85,193],"cell":[70,165],"presence":[73,112,173],"IL-6/sIL-6R":[75,114,139,196,225,247],"days":[78],"then":[80,116],"NFATc1":[81,187],"mRNA":[82,188],"cells":[86],"examined.":[88,132],"parthenolide":[93],"[PAR,":[94],"signal":[95],"transducer":[96],"activator":[98],"transcription":[100],"(STAT)":[101],"inhibitor]":[102],"PD98059":[104],"(PD,":[105],"mitogen-activated":[106],"protein":[107],"kinase":[108],"inhibitor)":[109],"these":[120],"drugs":[121],"phosphorylation":[123,198],"STAT3":[125,200],"ERK1/2,":[127],"RESULTS:":[133],"induced":[137,179,191,197,227],"(but":[140],"not":[141,155],"alone)":[143],"IL-1beta.":[146],"On":[147],"other":[149],"hand,":[150],"TNF-alpha":[151,176,240],"did":[154,222],"induce":[156],"expression,":[158,219],"although":[159],"growth":[166],"production.":[169],"However,":[170],"sIL-6R,":[175],"expression.":[181],"By":[182],"co-culture":[184],"RA-FLS,":[186,204],"cells.":[194],"Finally,":[195],"ERK1/2":[202],"completely":[207,215],"inhibited":[208,216],"PAR":[210,214],"PD,":[212],"respectively.":[213],"IL-6/sIL-6R-induced":[217],"but":[220],"PD":[221],"not.":[223],"CONCLUSIONS:":[224],"directly":[226],"it":[233],"is":[234,248],"essential":[235],"induction":[238,245],"IL-17.":[242],"Moreover,":[243],"mediated":[249],"janus":[252],"kinase/STAT":[253],"signalling":[254],"pathway.":[255]},"counts_by_year":[{"year":2026,"cited_by_count":15},{"year":2025,"cited_by_count":17},{"year":2024,"cited_by_count":29},{"year":2023,"cited_by_count":17},{"year":2022,"cited_by_count":33},{"year":2021,"cited_by_count":19},{"year":2020,"cited_by_count":31},{"year":2019,"cited_by_count":18},{"year":2018,"cited_by_count":23},{"year":2017,"cited_by_count":21},{"year":2016,"cited_by_count":17},{"year":2015,"cited_by_count":17},{"year":2014,"cited_by_count":22},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":19}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}
